tradingkey.logo
tradingkey.logo
Search

Zimmer Biomet Holdings Inc

ZBH
Add to Watchlist
84.370USD
+1.000+1.20%
Market hours ETQuotes delayed by 15 min
16.32BMarket Cap
21.82P/E TTM

Zimmer Biomet Holdings Inc

84.370
+1.000+1.20%

More Details of Zimmer Biomet Holdings Inc Company

Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.

Zimmer Biomet Holdings Inc Info

Ticker SymbolZBH
Company nameZimmer Biomet Holdings Inc
IPO dateJul 25, 2001
CEOTornos (Ivan)
Number of employees17000
Security typeOrdinary Share
Fiscal year-endJul 25
Address345 E Main St
CityWARSAW
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code46580-2746
Phone15742676131
Websitehttps://www.zimmerbiomet.com/en
Ticker SymbolZBH
IPO dateJul 25, 2001
CEOTornos (Ivan)

Company Executives of Zimmer Biomet Holdings Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
83.19K
+18.64%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
69.48K
+11.80%
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
66.30K
+6.11%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
32.01K
+29.41%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
10.19K
+7.91%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Paul A. Stellato
Mr. Paul A. Stellato
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
5.23K
+20.18%
Mr. Jehanzeb Noor
Mr. Jehanzeb Noor
Senior Vice President, Chief Strategy, Innovation and Business Development Officer
Senior Vice President, Chief Strategy, Innovation and Business Development Officer
5.15K
+96.08%
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
83.19K
+18.64%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
69.48K
+11.80%
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
66.30K
+6.11%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
32.01K
+29.41%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
10.19K
+7.91%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Knees
3.32B
40.36%
S E T
2.15B
26.12%
Hips
2.09B
25.43%
Other product category
665.60M
8.09%
By RegionUSD
Name
Revenue
Proportion
United States
4.76B
57.88%
International
3.47B
42.12%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Knees
3.32B
40.36%
S E T
2.15B
26.12%
Hips
2.09B
25.43%
Other product category
665.60M
8.09%

Shareholding Stats

Updated: Mon, May 11
Updated: Mon, May 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Dodge & Cox
12.15%
T. Rowe Price Associates, Inc.
6.89%
Vanguard Capital Management, LLC
6.61%
Harris Associates L.P.
6.34%
BlackRock Institutional Trust Company, N.A.
5.70%
Other
62.31%
Shareholders
Shareholders
Proportion
Dodge & Cox
12.15%
T. Rowe Price Associates, Inc.
6.89%
Vanguard Capital Management, LLC
6.61%
Harris Associates L.P.
6.34%
BlackRock Institutional Trust Company, N.A.
5.70%
Other
62.31%
Shareholder Types
Shareholders
Proportion
Investment Advisor
54.57%
Investment Advisor/Hedge Fund
46.04%
Research Firm
1.93%
Hedge Fund
1.78%
Pension Fund
1.60%
Bank and Trust
1.35%
Sovereign Wealth Fund
1.29%
Individual Investor
0.18%
Family Office
0.05%

Institutional Shareholding

Updated: Sun, Apr 5
Updated: Sun, Apr 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
1564
198.58M
101.82%
--
2026Q1
1955
204.65M
105.78%
-2.47M
2025Q4
1949
199.14M
100.48%
-6.16M
2025Q3
1945
195.45M
98.66%
-607.37K
2025Q2
1996
190.39M
96.22%
-5.04M
2025Q1
2047
189.51M
95.78%
-9.49M
2024Q4
2042
186.55M
93.71%
-18.21M
2024Q3
1986
185.93M
91.29%
-23.02M
2024Q2
1982
190.82M
92.76%
-16.12M
2024Q1
1974
190.22M
92.57%
-13.55M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Dodge & Cox
23.51M
12.01%
+290.68K
+1.25%
Dec 31, 2025
T. Rowe Price Associates, Inc.
13.34M
6.82%
-1.44M
-9.74%
Dec 31, 2025
Harris Associates L.P.
12.26M
6.27%
+7.51M
+158.17%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
11.02M
5.63%
-39.20K
-0.35%
Dec 31, 2025
State Street Investment Management (US)
8.83M
4.51%
+195.21K
+2.26%
Dec 31, 2025
Capital International Investors
7.13M
3.64%
-422.84K
-5.60%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.23M
2.68%
+36.61K
+0.70%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Langar Global HealthTech ETF
4.98%
VanEck Morningstar Wide Moat Value ETF
4.58%
Leatherback Long/Short Alternative Yield ETF
2.9%
VanEck Morningstar Wide Moat ETF
2.46%
iShares U.S. Medical Devices ETF
2.37%
First Trust Indxx Medical Devices ETF
2.13%
American Century Focused Large Cap Value ETF
2.03%
Invesco Raymond James SB-1 Equity ETF
1.87%
First Trust Health Care Alphadex Fund
1.78%
State Street SPDR S&P Health Care Equipment ETF
1.75%
View more
Langar Global HealthTech ETF
Proportion4.98%
VanEck Morningstar Wide Moat Value ETF
Proportion4.58%
Leatherback Long/Short Alternative Yield ETF
Proportion2.9%
VanEck Morningstar Wide Moat ETF
Proportion2.46%
iShares U.S. Medical Devices ETF
Proportion2.37%
First Trust Indxx Medical Devices ETF
Proportion2.13%
American Century Focused Large Cap Value ETF
Proportion2.03%
Invesco Raymond James SB-1 Equity ETF
Proportion1.87%
First Trust Health Care Alphadex Fund
Proportion1.78%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.75%

Dividend

A total of 798.20M USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 23, 2026
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2026 going ex on Mar 31, 2026 with reinvestment option
Mar 31, 2026
Apr 30, 2026
Mar 31, 2026
Dec 17, 2025
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 30, 2026 going ex on Dec 30, 2025 with reinvestment option
Dec 30, 2025
Jan 30, 2026
Dec 30, 2025
Aug 27, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2025 going ex on Sep 30, 2025 with reinvestment option
Sep 30, 2025
Oct 31, 2025
Sep 30, 2025
May 30, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2025 going ex on Jun 26, 2025
Jun 26, 2025
Jul 31, 2025
Jun 26, 2025
Feb 26, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2025 going ex on Mar 31, 2025
Mar 31, 2025
Apr 30, 2025
Mar 31, 2025
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024 with reinvestment option
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Aug 29, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2024 going ex on Sep 30, 2024 with reinvestment option
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 13, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2024 going ex on Jun 26, 2024 with reinvestment option
Jun 26, 2024
Jul 31, 2024
Jun 26, 2024
Feb 21, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
View more

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI